ANAB compared with TRAX: revenue, margins and what each company keeps, and the suppliers and customers both name

ANABAnaptysbio, Inc

Mkt capRevenueRevenue

TRAXFirst Tracks Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

ANABAnaptysbio, Inc

TRAXFirst Tracks Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ANAB 4

VNDAVanda Pharmaceuticalscustomer

GSKGSKcustomer

—DRI Healthcare Trustunlistedsupplier

—Sagard Healthcare Royalty Partnersunlistedsupplier

Shared 0

No shared counterparties.

Only TRAX 1

—Centessa Pharmaceuticals (UK)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ANABAnaptysbio, Inc

48.42· pre 48.43· delayed

Mkt cap$1.4BRevenue$26MQ1 FY26Revenue$235MFY25

TRAXFirst Tracks Biotherapeutics, Inc.

45.20· pre 45.70

Pre-marketSep 2 '83

Mkt cap$1.6BRevenue—Revenue—

Compare

Pre-marketSep 2 '83

ANABAnaptysbio, Inc

TRAXFirst Tracks Biotherapeutics, Inc.

48.42pre 48.43delayed

Price

45.20pre 45.70

$1.4B

Mkt cap

$1.6B

Q1 FY26$26M

Revenue

—

FY25$235M

Revenue

—

ANAB48.42vsTRAX45.20Pre-marketSep 2 '83